These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 40173)

  • 41. [Drug resistance of bacteria--the present status and the future prospect. 1. Streptococcus pneumoniae].
    Oguri T
    Nihon Rinsho; 1984 Mar; 42(3):651-7. PubMed ID: 6471456
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group.
    Gómez-Garcés JL; Alós JI; Cogollos R
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):69-73. PubMed ID: 7805358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.
    Schmitz FJ; Boos M; Mayer S; Verhoef J; Milatovic D; Fluit AC
    J Antimicrob Chemother; 2001 Jul; 48(1):148-52. PubMed ID: 11418531
    [No Abstract]   [Full Text] [Related]  

  • 44. Susceptibility testing of Streptococcus pneumoniae to trimethoprim.
    Tremlett CH; Richards JE
    J Antimicrob Chemother; 1995 Jun; 35(6):915-6. PubMed ID: 7559204
    [No Abstract]   [Full Text] [Related]  

  • 45. Accuracy of routine susceptibility testing of Streptococcus pneumoniae in England and Wales.
    Henwood CJ; Warner M; Waight P; Johnson AP; George RC; Livermore DM
    J Antimicrob Chemother; 2001 Jun; 47(6):897-900. PubMed ID: 11389129
    [No Abstract]   [Full Text] [Related]  

  • 46. Study of vancomycin tolerance in 120 strains of Streptococcus pneumoniae isolated in 1999 in Madrid, Spain.
    Antón N; Blázquez R; Gómez-Garcés JL; Alós JI
    J Antimicrob Chemother; 2001 Jun; 47(6):902-3. PubMed ID: 11389131
    [No Abstract]   [Full Text] [Related]  

  • 47. Another episode in the continuing conflict.
    Barlow JF
    S D J Med; 1995 Sep; 48(9):299. PubMed ID: 7481723
    [No Abstract]   [Full Text] [Related]  

  • 48. PHLS surveillance of antibiotic resistance, England and Wales: emerging resistance in Streptococcus pneumoniae.
    Speller DC; Johnson AP; Cookson BD; Waight P; George RC
    Emerg Infect Dis; 1996; 2(1):57-8. PubMed ID: 8903198
    [No Abstract]   [Full Text] [Related]  

  • 49. Susceptibility of Streptococcus pneumoniae to five antibiotics.
    Florez C; Perez MJ; Aretio R; Parras D; Martin E
    J Antimicrob Chemother; 1992 Nov; 30(5):727-8. PubMed ID: 1493991
    [No Abstract]   [Full Text] [Related]  

  • 50. Susceptibility of pneumococci to evernimicin: effect of CO2 and different methodologies.
    Hamilton-Miller JM; Shah S; Loebenberg D
    Clin Microbiol Infect; 2001 Jun; 7(6):339-40. PubMed ID: 11442569
    [No Abstract]   [Full Text] [Related]  

  • 51. [Multi-antibiotic-resistant pneumococcus. A new case].
    Quentin C; Cardoso-Mendes I; Schue P; Janvier G; Bebear C
    Presse Med; 1985 Feb; 14(8):489. PubMed ID: 3157155
    [No Abstract]   [Full Text] [Related]  

  • 52. Tetracycline-resistant group A streptococci and pneumococci.
    Kahlmeter G; Kamme C
    Scand J Infect Dis; 1972; 4(3):193-6. PubMed ID: 4404850
    [No Abstract]   [Full Text] [Related]  

  • 53. [Behavior of Diplococcus mucosus (B. antitratum) in experimental resistance tests].
    LINZENMEIER G
    Zentralbl Bakteriol Orig; 1955 Aug; 163(5-6):348-52. PubMed ID: 13257682
    [No Abstract]   [Full Text] [Related]  

  • 54. Chloramphenicol-resistant pneumococci in West Africa.
    Hansman D
    Lancet; 1978 May; 1(8073):1102-3. PubMed ID: 77402
    [No Abstract]   [Full Text] [Related]  

  • 55. Missing in action: an antimicrobial resistance strategy for New Zealand.
    Williamson D; Baker M; French N; Thomas M
    N Z Med J; 2015 Dec; 128(1427):65-7. PubMed ID: 26914007
    [No Abstract]   [Full Text] [Related]  

  • 56. In-vitro ranking of the efficacy of antimicrobial agents.
    Tajima Y
    J Antimicrob Chemother; 1997 Mar; 39(3):401-4. PubMed ID: 9096190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility of Streptococcus pneumoniae to chloramphenicol and thiamphenicol.
    Glupczynski Y; Yourassowsky E; Van der Linden MP; Crokaert F
    J Antimicrob Chemother; 1983 May; 11(5):488-9. PubMed ID: 6874634
    [No Abstract]   [Full Text] [Related]  

  • 58. Reinterpretation of susceptibility data using current NCCLS breakpoint criteria.
    Jones ME; Karlowsky JA; Blosser-Middleton R; Critchley I; Karginova E; Thornsberry C; Sahm DF
    Antimicrob Agents Chemother; 2003 Feb; 47(2):830. PubMed ID: 12543705
    [No Abstract]   [Full Text] [Related]  

  • 59. Resistance of Streptococcus pneumoniae from Saudi Arabia.
    Rahman EA; Dixon RA
    Int J Antimicrob Agents; 1999 Sep; 13(1):61-2. PubMed ID: 10563407
    [No Abstract]   [Full Text] [Related]  

  • 60. PREVALENCE OF TETRACYCLINE-RESISTANT DIPLOCOCCUS PNEUMONIAE.
    RAGSDALE AR; SANFORD JP
    Antimicrob Agents Chemother (Bethesda); 1964; 10():164-7. PubMed ID: 14287923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.